2021: Global Economic Outlook
Key takeaways
1
2
3
With major European economies such as Germany, France, Italy, Spain and the UK all embarking on new nationwide lockdowns (as opposed to local lockdowns), and the US experiencing new records in daily infections, there is no immediate relief in sight for these economies.
This means that the fourth quarter of 2020 may well see declines in real GDP, to be followed by an uncertain trajectory in 2021. The year ahead could include a weak first quarter in the northern hemisphere while the virus persists, to be followed by relatively strong bounce-backs through the second and third quarters, especially if a vaccine becomes widely available. The recoveries in 2021 will likely be boosted by the huge monetary and fiscal stimulus policies adopted by central banks and governments across the developed world.
Once the return to normality is widely perceived to be under way with consumers and service businesses regaining confidence, we expect a significant transformation of the economic environment - in striking contrast to the aftermath of the GFC when recovery was sub-par and anaemic for a long period. This means that consumption, investment and employment are all likely to recover at a much more rapid pace than after a typical recession, generating a surprisingly strong bounce-back.
Investment risks
-
The value of investments and any income will fluctuate (this may partly be as a result of exchange rate fluctuations) and investors may not get back the full amount invested.
Important information
-
Where individuals or the business have expressed opinions, they are based on current market conditions, they may differ from those of other investment professionals and are subject to change without notice.
This document is marketing material and is not intended as a recommendation to invest in any particular asset class, security or strategy. Regulatory requirements that require impartiality of investment/investment strategy recommendations are therefore not applicable nor are any prohibitions to trade before publication. The information provided is for illustrative purposes only, it should not be relied upon as recommendations to buy or sell securities.